Lynne Belle-Isle

April 1, 2024

Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

Abstract Background: One in five individuals live with chronic pain globally, which often co-occurs with sleep problems, anxiety, depression, and…

May 24, 2020

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review

Abstract Introduction: Chronic pain and co-occurring disorders, such as sleep disorders, anxiety, depression, post-traumatic stress disorder and substance use disorders,…

March 25, 2018

Species‐specific susceptibility to cannabis‐induced convulsions

Abstract Background and Purpose: Numerous claims are made for cannabis’ therapeutic utility upon human seizures, but concerns persist about risks.…